mevalonic acid has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angelini, D; Battistini, L; Boccadoro, M; Bosia, A; Castella, B; Chiaretti, S; Coscia, M; Drandi, D; Foà, R; Foglietta, M; Fournié, JJ; Griggio, V; Guarini, A; Ladetto, M; Massaia, M; Peola, S; Riganti, C; Rigoni, M; Vitale, C | 1 |
1 other study(ies) available for mevalonic acid and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Blotting, Western; Bone Density Conservation Agents; Case-Control Studies; Cell Differentiation; Cells, Cultured; Diphosphonates; Female; Follow-Up Studies; Gene Expression Profiling; Geranyltranstransferase; Humans; Imidazoles; Immunologic Memory; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Activation; Male; Mevalonic Acid; Middle Aged; Oligonucleotide Array Sequence Analysis; Real-Time Polymerase Chain Reaction; Receptors, Antigen, T-Cell, gamma-delta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Survival Rate; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Zoledronic Acid | 2012 |